EQUASENS (Pharmagest Interactive): ANNUAL ORDINARY GENERAL MEETING PRELIMINARY NOTICE
Villers-lès-Nancy, 30 May 2022 – 6:00 p.m. (CET)
PRESS RELEASE
ANNUAL ORDINARY GENERAL MEETING
PRELIMINARY NOTICE
EQUASENS (formally PHARMAGEST INTERACTIVE) hereby provides notice to shareholders of the Annual Ordinary General Meeting to be held on Thursday, June 28, 2022 at 5.00 pm at the Company’s registered office located in Villers-lès-Nancy (Technopôle de Nancy-Brabois – 5 Allée de Saint Cloud).
The agenda and the draft resolutions were published in the BALO n°60 (Bulletin des Annonces Légales et Obligatoires) of May 20, 2022 (www.journal-officiel.gouv.fr) and on the company’s website (www.equasens.com).
Pursuant to article R.22-10-23 of the French commercial code, EQUASENS will publish the documents prescribed by this article 21 days prior to the meeting on its website
https://equasens.com/investisseurs/assemblee-generale/.
For the purpose of communications between the Company and its shareholders, it is strongly recommended that requests or documents be sent, in priority, by email, to the following address: actionnaires@equasens.com.
About Equasens Group:
With more than 1,200 employees fulfilling a vital role as “Citizens in the Service of Health and Well-Being”, Equasens Group is today a key player in the European healthcare sector, providing software solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, Hospital-at-Home structures, retirement homes, health centres) in both primary and secondary care sectors.
With operations in France, Italy, Belgium, Luxembourg and the United Kingdom, Equasens Group is currently developing the leading healthcare platform and a unique ecosystem in France and Europe benefiting people by making available the very best of technology.
Listed on Euronext Paris™ – Compartment A
Indexes: MSCI GLOBAL SMALL CAP – GAÏA Index 2020 – CAC® SMALL and CAC® All-Tradable
Included under the European Rising Tech label.
Eligible for the Deferred Settlement Service (“Service à Réglement Différé” – SRD) and equity savings accounts invested in small and mid caps (PEA-PME).
ISIN: FR0012882389 – Ticker Code to be confirmed
For all the latest news on Equasens Group go to www.equasens.com
CONTACTS
Analyst and Investor Relations:
Chief Administrative and Financial Officer: Jean-Yves SAMSON
Tel. +33 (0)3 83 15 90 67 – jean-yves.samson@equasens.com
Media Relations:
FIN’EXTENSO – Isabelle APRILE
Tel. +33 (0)1 39 97 61 22 – i.aprile@finextenso.fr
Attachment
